Results 71 to 80 of about 74,762 (206)

Natural history of decompensated cirrhosis with serum hepatitis B DNA < 2000 IU/mL: a retrospective study

open access: yesBMC Gastroenterology, 2022
Background and aims Patients with low HBV DNA levels (
Xu Huang   +5 more
doaj   +1 more source

IL28B is associated with outcomes of chronic HBV infection [PDF]

open access: yes, 2015
Purpose The role of IL28B gene variants and expression in hepatitis B virus (HBV) infections are not well understood. Here, we evaluated whether IL28B gene expression and rs12979860 variations are associated with HBV outcomes.
Chi, Xiumei   +11 more
core   +1 more source

Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy

open access: yesInternational Journal of Infectious Diseases
Objectives: To unravel the still unexplored HBV-replicative kinetics in anti-HBc-positive/HBsAg-negative people-with-HIV (PWH) suspending tenofovir disoproxil-fumarate/tenofovir-alafenamide (TDF/TAF).
Romina Salpini   +16 more
doaj   +1 more source

Insights into Hepatitis B Virus DNA Integration-55 Years after Virus Discovery

open access: yesThe Innovation, 2020
Hepatitis B virus (HBV), which was discovered in 1965, is a threat to global public health. HBV infects human hepatocytes and leads to acute and chronic liver diseases, and there is no cure.
Kaitao Zhao, Andrew Liu, Yuchen Xia
doaj   +1 more source

Long-Term Hepatitis B Virus (HBV) Response to Lamivudine-Containing Highly Active Antiretroviral Therapy in HIV-HBV Co-Infected Patients in Thailand [PDF]

open access: yes, 2012
Background: Approximately 4 million of people are co-infected with HIV and Hepatitis B virus (HBV). In resource-limited settings, the majority of HIV-infected patients initiate first-line highly active antiretroviral therapy containing lamivudine (3TC ...
Alain Goudeau   +13 more
core   +2 more sources

Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure. [PDF]

open access: yes, 2019
Hepatitis B virus (HBV) is one of the most significant hepatocarcinogens. The ultimate goal of anti-HBV treatment is to prevent the development of hepatocellular carcinoma (HCC).
Coben, Robert M.   +7 more
core   +1 more source

Dynamic comparison between Daan real-time PCR and Cobas TaqMan for quantification of HBV DNA levels in patients with CHB [PDF]

open access: yes, 2014
BACKGROUND: Hepatitis B virus (HBV) DNA levels are crucial for managing chronic hepatitis B (CHB). It was unclear whether Daan real-time polymerase chain reaction test (Daan test) or COBAS TaqMan HBV DNA Test (Cobas TaqMan) was superior in measuring ...
Fang-fang Lv   +4 more
core   +1 more source

The enzymes LSD1 and Set1A cooperate with the viral protein HBx to establish an active hepatitis B viral chromatin state [PDF]

open access: yes, 2016
Indexación: Web of ScienceWith about 350 million people chronically infected around the world hepatitis B is a major health problem. Template for progeny HBV synthesis is the viral genome, organized as a minichromosome (cccDNA) inside the hepatocyte ...
Alarcon, V   +9 more
core   +2 more sources

Kroonilise B-hepatiidi jälgimise ja ravi soovitused [PDF]

open access: yes, 2013
B-hepatiidi jälgimise ja ravi soovituste eesmärgiks on tutvustada kroonilise B-hepatiidi haige jälgimise ja viirusevastase ravi tänapäevaseid põhimõtteid, et vältida lõppstaadiumis maksatsirroosi ja maksarakk-kasvaja teket.
Maimets, Matti   +4 more
core   +2 more sources

Occult HBV infection among Egyptian hepatocellular carcinoma patients

open access: yesVirology Journal, 2011
Background Occult HBV infection accelerates the progression of liver fibrosis, cirrhosis, and finally leading to hepatocellular carcinoma (HCC). This study analyzed the occult HBV-genotypes in HCC patients. Methods To achieve our objective, matched serum
Mansor Tarek M   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy